Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Prediction of indirect interactions in proteins
A phase 2B clinical trial (HARMONY) revealed that efruxifermin, a bivalent Fc-FGF21 analog, improved hepatic inflammation and fibrosis over 24 weeks in patients with F2 or F3 fibrosis, with an acceptable safety profile, warranting further investigation in phase 3 trials (NCT04767529)
The Wnt/-catenin signaling pathway target genes Lgr6 , lef1 , and Tcf7 (Lien et al., 2014) showed elevated expression, while the expression of Wnt inhibitors Sfrp4 , Sfrp5 , and Dkk1 (Huyghe et al., 2015
You are losing, and the rate will increase with each dose escalation
US$ 20.11
US$ 21.12
US$ 22.89
US$ 27.27
US$ 26.56
US$ 28.98
